Kincell Bio, a cell therapy developer and manufacturer, has appointed Larry Pitcher as Chief Operating Officer (COO).

Delpharm, a CDMO, has reached an agreement with the Government of Canada to modernize its injectable manufacturing facility in Boucherville.

Huyabio International has appointed Paul Spreen as Chief Business Officer. “We are delighted to welcome Paul Spreen to the HUYA executive team,” said Dr. Mireille Gillings, President, CEO & Executive ...

Araris is advancing three preclinical candidates for the treatment of hematological and solid tumors developed using its ...

Humanetics Corporation, a clinical-stage pharmaceutical company, has selected Lifecore Biomedical, a fully integrated CDMO, ...

To leverage Alteogen's ALT-B4 Hybrozyme platform technology for large volume subcutaneous administration of drugs.

The combination of Mallinckrodt and Endo will create a strong pharmaceutical company with a diversified portfolio, enhanced ...

Curia will expand its Glasgow, UK facility and offers updates on the ongoing expansion to its Albuquerque, NM facility.

Funds will help the companies create a platform for the manufacturing and characterization of AAV-based gene therapy vectors.

Oncologi, Inc., a clinical-stage biopharmaceutical company, announced the acquisition of TargImmune Therapeutics, a biotechnology company specializing in novel tumor-targeted imm ...

Achieves ISO9001, EFfCI GMP, and EXCiPACT certifications for its new manufacturing plant.

PranaX Corporation, a pioneer in exosome-based regenerative wellness, has appointed Phillip Maderia as its new Chief Executive Officer.